Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Completed
National Cancer Institute (NCI)
Phase 2
2009-08-20
This phase II trial is studying how well giving acetylsalicylic acid together with
eflornithine works in treating patients at high risk for colorectal cancer. Chemoprevention
is the use of certain drugs to keep cancer from forming. The use of acetylsalicylic acid and
eflornithine may prevent colorectal cancer.
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
Completed
National Cancer Institute (NCI)
Phase 2
2014-06-01
This randomized phase II trial studies the safety and effects of acetylsalicylic acid
(aspirin) taken continuously or intermittently on gene expression in the nasal tissue of
current smokers. Smokers are at increased risk of developing lung cancer. Acetylsalicylic
acid may be useful in preventing lung cancer.
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
Completed
National Cancer Institute (NCI)
Phase 2
2014-11-21
This randomized phase II trial studies acetylsalicylic acid compared to placebo in treating
high-risk patients with subsolid lung nodules. A nodule is a growth or lump that may be
malignant (cancer) or benign (not cancer). Chemoprevention is the use of drugs to keep cancer
from forming or coming back. The use of acetylsalicylic acid may keep cancer from forming in
patients with subsolid lung nodules.
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
Completed
National Cancer Institute (NCI)
Phase 2
2016-01-13
This randomized phase II trial studies the effects of aspirin and zileuton on genes related
to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to
tobacco use and may be useful in preventing lung cancer in current smokers.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
